7 active trials 2 recruiting 4 disease areas
| Early Phase 1 | 3 | |
| Phase 1 | 3 | |
| Phase 1/2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 1/2 | ||||
| NCT04440436 | Assessment of Safety and Efficacy of IM19 for Recurrent or Refractory (R/R) Non-Hodgkin's… | NHL | Recruiting | 2020-12-08 |
| Phase 1 | ||||
| NCT06718738 | Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Colorectal Cancer | Colorectal Cancer (CRC) | Recruiting | 2024-12-05 |
| NCT07406984 | Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Adenocarcinoma of… | Adenocarcinoma of Gastric | Not Yet Recruiting | 2026-02-13 |
| NCT06852573 | Clinical Study of ZM001 Injection in the Treatment of Refractory Systemic Lupus… | Systemic Lupus Erythematosus | Not Yet Recruiting | 2025-02-28 |
| Early Phase 1 | ||||
| NCT06886919 | Clinical Study Evaluating the Safety and Efficacy of IC19 CAR-T Cell Therapy for… | Difficult to Treat Systemic Lupus Erythematosus | Not Yet Recruiting | 2025-03-24 |
| NCT06690359 | IM19 CAR-T Cell Therapy for IgA Nephropathy Patients and Membranous Nephropathy Patients | IgA Nephropathy | Not Yet Recruiting | 2024-11-26 |
| NCT06691308 | WL276 CAR-T Cell Therapy for CD276 Positive Recurrent or Progressive Glioblastoma Patients | Recurrent or Progressive Glioblastoma | Not Yet Recruiting | 2024-11-18 |
Lupus (SLE) (2) · Colorectal Cancer (1) · Glioblastoma (1) · Non-Hodgkin Lymphoma (1)